Press Releases

September 9, 2021

TransCelerate BioPharma Commences Collaborative Development of a Novel Digital Data Flow Solution for Study Start-Up

TransCelerate BioPharma Inc. (TransCelerate) announced today that it has commenced development on a reference implementation of a study definitions repository. The study definitions repository is a novel central component aimed at facilitating the exchange of structured study definitions across clinical systems using technical and data standards. For the full press release, please click here.

Explore

June 7, 2021

BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research, today announced that it has released the first set of its solutions as part of its Public Private Partnership (PPP) with the U.S. Food & Drug Administration’s Center for Drug Evaluation and…

Explore

October 19, 2020

TransCelerate Launches New Initiatives to Support COVID-19 Research, R&D of Medicines, & More

DataCelerate® COVID-19 Module, Modernizing Critical Trial Conduct, Real World Data and Pharmacovigilance Agreements Optimization were all launched to support the continuity of clinical trials. We’ve also elected new Board leaders and added Bayer Pharmaceuticals as our newest member.

Explore

June 17, 2020

TransCelerate Expands COVID-19 Clinical Trial Data Sharing to Include All Biopharma Companies and BioMedical Research Institutions

TransCelerate BioPharma Inc., a non-profit collaboration comprised of 20 of the largest biopharmaceutical companies, today announced that it is expanding access to COVID-19-related patient-level clinical data sharing via DataCelerate® to non-member companies. In addition, TransCelerate will expand the type of data shared to include data from both the investigational product and control arms of COVID-19 clinical trials.…

Explore

April 15, 2020

TransCelerate BioPharma Member Companies Commit to Share COVID-19 Related Clinical Data via DataCelerate®

TransCelerate BioPharma Inc. announced that it will be utilizing its DataCelerate® platform to share Member Company control arm data from ongoing and planned COVID-19 clinical studies, as well as data from past studies in related diseases or patient populations. For the full press release click here.

Explore

June 10, 2019

BioCelerate Launches Two New Initiatives and Expands Membership

Explore

May 23, 2019

TransCelerate BioPharma Launches Three New Initiatives and Expands Membership

TransCelerate announced it has committed to an expansion of its clinical and drug safety portfolio, revealing three new initiatives: the Common Clinical Serious Adverse Events Fields Initiative, the Modernization of Data Analytics for Clinical Development Initiative and the Interpretation of Guidances and Regulations Initiative.

Explore

August 3, 2018

TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing

DataCelerateTM Seamlessly Connects Clean, Converted Clinical & Preclinical Information within One Data Lake Solution.

Explore

May 18, 2018

TransCelerate Launches New Initiatives in Automation, Analytics and Data Quality

TransCelerate announced the addition of several new initiatives to its expanded portfolio that leverage advancements in automation and analytics and focus on data quality, safety and integrity.

Explore

April 6, 2018

“One Person Closer” Campaign Launches to Inspire & Empower Conversation between Healthcare Professionals and their Patients on Clinical Trial Participation

Explore